| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.PT.2003.09.003 |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:S1471492203002435?httpAccept=text/xml |
| https://api.elsevier.com/content/article/PII:S1471492203002435?httpAccept=text/plain | ||
| P698 | PubMed publication ID | 14580964 |
| P5875 | ResearchGate publication ID | 9038199 |
| P50 | author | William A. Petri | Q27663335 |
| P2860 | cites work | Nitazoxanide pharmacokinetics and tolerability in man using single ascending oral doses | Q28202853 |
| Diloxanide furoate for treating asymptomatic Entamoeba histolytica cyst passers: 14 years' experience in the United States | Q28267759 | ||
| Estimating the impact of amebiasis on health | Q30305861 | ||
| A redescription of Entamoeba histolytica Schaudinn, 1903 (Emended Walker, 1911) separating it from Entamoeba dispar Brumpt, 1925. | Q34366328 | ||
| In vitro activity of nitazoxanide and related compounds against isolates of Giardia intestinalis, Entamoeba histolytica and Trichomonas vaginalis | Q38859525 | ||
| Epidemiology of amebiasis in a region of high incidence of amebic liver abscess in central Vietnam. | Q38911916 | ||
| Successful treatment of metronidazole- and albendazole-resistant giardiasis with nitazoxanide in a patient with acquired immunodeficiency syndrome | Q43613085 | ||
| Treatment of diarrhea caused by Cryptosporidium parvum: a prospective randomized, double-blind, placebo-controlled study of Nitazoxanide | Q43634110 | ||
| Treatment of diarrhea caused by Giardia intestinalis and Entamoeba histolytica or E. dispar: a randomized, double-blind, placebo-controlled study of nitazoxanide | Q43666861 | ||
| Metronidazole in amoebic dysentery and amoebic liver abscess | Q43756524 | ||
| Treatment of asymptomatic intestinal Entamoeba histolytica infection | Q44192143 | ||
| Effect of nitazoxanide on morbidity and mortality in Zambian children with cryptosporidiosis: a randomised controlled trial | Q44210953 | ||
| Intrahepatic amebic abscesses: indications for and results of percutaneous catheter drainage | Q44865025 | ||
| Paromomycin in the treatment of mild-to-moderate intestinal amebiasis | Q46845231 | ||
| Innate and acquired resistance to amebiasis in bangladeshi children. | Q53960924 | ||
| Treatment of patients with refractory giardiasis. | Q54006010 | ||
| Placebo-controlled trial of co-trimoxazole for Cyclospora infections among travellers and foreign residents in Nepal | Q72618410 | ||
| Treatment with albendazole for intestinal disease due to Enterocytozoon bieneusi in patients with AIDS | Q72695823 | ||
| Cyclospora infection in adults infected with HIV. Clinical manifestations, treatment, and prophylaxis | Q72764059 | ||
| Nitazoxanide: pharmacokinetics and metabolism in man | Q74307332 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | protozoa | Q101274 |
| P304 | page(s) | 523-526 | |
| P577 | publication date | 2003-11-01 | |
| P1433 | published in | Trends in Parasitology | Q15265846 |
| P1476 | title | Therapy of intestinal protozoa | |
| P478 | volume | 19 |
| Q41428589 | A new anthraquinone from Morinda elliptica Ridl |
| Q61449726 | Antiamoebic drugs for treating amoebic colitis |
| Q28481304 | Biochemical, mutational and in silico structural evidence for a functional dimeric form of the ornithine decarboxylase from Entamoeba histolytica |
| Q36052733 | Chew on this: amoebic trogocytosis and host cell killing by Entamoeba histolytica |
| Q37652864 | Conjugation of metronidazole with dextran: a potential pharmaceutical strategy to control colonic distribution of the anti-amebic drug susceptible to metabolism by colonic microbes |
| Q34601985 | Current therapeutics, their problems, and sulfur-containing-amino-acid metabolism as a novel target against infections by "amitochondriate" protozoan parasites |
| Q34638388 | Discovery of Entamoeba histolytica hexokinase 1 inhibitors through homology modeling and virtual screening. |
| Q36407048 | Efficacy of eleven antimicrobials against a gregarine parasite (Apicomplexa: Protozoa). |
| Q43722294 | Electron microscopic observation of the invasion process of Cryptosporidium parvum in severe combined immunodeficiency mice |
| Q42116901 | Giardial triosephosphate isomerase as possible target of the cytotoxic effect of omeprazole in Giardia lamblia |
| Q26772350 | Immune Evasion Mechanisms of Entamoeba histolytica: Progression to Disease |
| Q27301395 | Modeling long-term host cell-Giardia lamblia interactions in an in vitro co-culture system |
| Q30363533 | Molecular modeling on pyruvate phosphate dikinase of Entamoeba histolytica and in silico virtual screening for novel inhibitors. |
| Q38817426 | Novel aryl carbamate derivatives of metronidazole as potential antiamoebic agents |
| Q26776140 | Parasitic diarrheal disease: drug development and targets |
| Q40257985 | Phenolic Acid Composition and Anti-Parasitic Effects of Four Peucedanum Species on Entamoeba histolytica Trophozoites |
| Q40460370 | Present and future control of cryptosporidiosis in humans and animals. |
| Q38088306 | Recent initiatives and strategies to developing new drugs for tropical parasitic diseases |
| Q97425431 | Speculative analysis on the electronic structure, IR assignments and molecular docking of N-{4-[(4-amino-3-phenyl-1H-pyrazolo[3,4-d]pyrimidin-1-yl)sulfonyl]phenyl}acetamide, an anti-amoebic agent |
| Q27670521 | Structure analysis of Entamoeba histolytica enolase |
| Q92603025 | Structure-based identification of a potential non-catalytic binding site for rational drug design in the fructose 1,6-biphosphate aldolase from Giardia lamblia |
| Q54347952 | Synthesis and evaluation of sulfate conjugated metronidazole as a colon-specific prodrug of metronidazole. |
| Q39044582 | Synthesis, characterization, and anti-amoebic activity of N-(pyrimidin-2-yl)benzenesulfonamide derivatives |
| Q39635318 | Synthesis, characterization, antiamoebic activity and cytotoxicity of new pyrazolo[3, 4-d]pyrimidine-6-one derivatives |
| Q39641860 | Synthesis, characterization, antiamoebic activity and cytotoxicity of novel 2-(quinolin-8-yloxy) acetohydrazones and their cyclized products (1,2,3-thiadiazole and 1,2,3-selenadiazole derivatives) |
| Q37586925 | The old and new therapeutic approaches to the treatment of giardiasis: where are we? |
| Q30426761 | Tissue destruction and invasion by Entamoeba histolytica |
| Q37707263 | Transcriptomics Indicates Active and Passive Metronidazole Resistance Mechanisms in Three Seminal Giardia Lines. |
| Q38911906 | Ultrasound patterns and frequency of focal liver lesions after successful treatment of amoebic liver abscess |
| Q81290497 | [Therapeutic alternatives after failure of primary treatment in digestive parasitic diseases in immune competent adult] |
Search more.